Two of four experimental drugs being tested for Ebola Virus Disease (EVD) in the Democratic Republic of the Congo (DRC) can cure the disease, the World Health Organization (WHO) said on August 12, 2019. EVD has claimed 1,866 lives in the DRC since August 1, 2018. As many as 2,781 EVD cases have been reported till date.
A trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with EVD began on November 20, 2018, in the DRC as part of the emergency response to an ongoing Ebola outbreak in the North Kivu and Ituri Provinces. “The preliminary results in 499 study participants indicated that those individuals receiving REGN-EB3 or mAb114 had a greater chance of survival compared to those participants in the other two arms,” a WHO press communique said. It added that the final analysis of the data could occur only after all data had been…
